Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
CPT: Pharmacometrics & Systems Pharmacology
|
January 20, 2019
Power Determination During Drug Development: Is Optimizing the Sample Size Based on Exposure-Response Analyses Underutilized?
Aksana K Jones, Ahmed Hamed Salem, Kevin J Freise
Clinical Pharmacokinetics
|
November 2, 2020
Population Pharmacokinetics of a Monthly Buprenorphine Depot Injection for the Treatment of Opioid Use Disorder: A Combined Analysis of Phase II and Phase III Trials
Aksana K Jones, Eliford Ngaimisi, Mathangi Gopalakrishnan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 20, 2019
Population Pharmacokinetics of Clofarabine as Part of Pretransplantation Conditioning in Pediatric Subjects before Hematopoietic Cell Transplantation
Hechuan Wang, Aksana K Jones, Christopher C Dvorak, et al.
Clinical and Translational Science
|
July 14, 2025
Sacituzumab Govitecan Population Pharmacokinetics: Updated Analyses Using HR+/HER2- Metastatic Breast Cancer Data From the Phase 3 TROPiCS-02 Trial
Abhishek G Sathe, Aksana K Jones, Paul M Diderichsen, et al.
The AAPS Journal
|
May 29, 2016
Clinical Predictors of Venetoclax Pharmacokinetics in Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma Patients: a Pooled Population Pharmacokinetic Analysis
Aksana K Jones, Kevin J Freise, Suresh K Agarwal, et al.
Cancer Chemotherapy and Pharmacology
|
September 3, 2016
Venetoclax does not prolong the QT interval in patients with hematological malignancies: an exposure-response analysis
Kevin J Freise, Martin Dunbar, Aksana K Jones, et al.
Hematological Oncology
|
December 17, 2016
Relationship between venetoclax exposure, rituximab coadministration, and progression-free survival in patients with relapsed or refractory chronic lymphocytic leukemia: demonstration of synergy
Kevin J Freise, Aksana K Jones, Rajeev M Menon, et al.
Clinical Pharmacokinetics
|
September 18, 2016
Impact of Venetoclax Exposure on Clinical Efficacy and Safety in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
Kevin J Freise, Aksana K Jones, Doerthe Eckert, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
CPT: Pharmacometrics & Systems Pharmacology
|
January 20, 2019
Power Determination During Drug Development: Is Optimizing the Sample Size Based on Exposure-Response Analyses Underutilized?
Aksana K Jones, Ahmed Hamed Salem, Kevin J Freise
Clinical Pharmacokinetics
|
November 2, 2020
Population Pharmacokinetics of a Monthly Buprenorphine Depot Injection for the Treatment of Opioid Use Disorder: A Combined Analysis of Phase II and Phase III Trials
Aksana K Jones, Eliford Ngaimisi, Mathangi Gopalakrishnan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 20, 2019
Population Pharmacokinetics of Clofarabine as Part of Pretransplantation Conditioning in Pediatric Subjects before Hematopoietic Cell Transplantation
Hechuan Wang, Aksana K Jones, Christopher C Dvorak, et al.
Clinical and Translational Science
|
July 14, 2025
Sacituzumab Govitecan Population Pharmacokinetics: Updated Analyses Using HR+/HER2- Metastatic Breast Cancer Data From the Phase 3 TROPiCS-02 Trial
Abhishek G Sathe, Aksana K Jones, Paul M Diderichsen, et al.
The AAPS Journal
|
May 29, 2016
Clinical Predictors of Venetoclax Pharmacokinetics in Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma Patients: a Pooled Population Pharmacokinetic Analysis
Aksana K Jones, Kevin J Freise, Suresh K Agarwal, et al.
Cancer Chemotherapy and Pharmacology
|
September 3, 2016
Venetoclax does not prolong the QT interval in patients with hematological malignancies: an exposure-response analysis
Kevin J Freise, Martin Dunbar, Aksana K Jones, et al.
Hematological Oncology
|
December 17, 2016
Relationship between venetoclax exposure, rituximab coadministration, and progression-free survival in patients with relapsed or refractory chronic lymphocytic leukemia: demonstration of synergy
Kevin J Freise, Aksana K Jones, Rajeev M Menon, et al.
Clinical Pharmacokinetics
|
September 18, 2016
Impact of Venetoclax Exposure on Clinical Efficacy and Safety in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
Kevin J Freise, Aksana K Jones, Doerthe Eckert, et al.
Page
of 1